These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 14670773)
1. Prospective randomised treatment with recombinant human growth hormone in cystic fibrosis. Schibler A; von der Heiden R; Birrer P; Mullis PE Arch Dis Child; 2003 Dec; 88(12):1078-81. PubMed ID: 14670773 [TBL] [Abstract][Full Text] [Related]
2. Submaximal exercise capacity in adolescent and adult patients with cystic fibrosis. Ziegler B; Rovedder PM; Lukrafka JL; Oliveira CL; Menna-Barreto SS; Dalcin Pde T J Bras Pneumol; 2007; 33(3):263-9. PubMed ID: 17906786 [TBL] [Abstract][Full Text] [Related]
3. Effect of a home exercise training program in patients with cystic fibrosis. de Jong W; Grevink RG; Roorda RJ; Kaptein AA; van der Schans CP Chest; 1994 Feb; 105(2):463-8. PubMed ID: 8306748 [TBL] [Abstract][Full Text] [Related]
4. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis. Schnabel D; Grasemann C; Staab D; Wollmann H; Ratjen F; Pediatrics; 2007 Jun; 119(6):e1230-8. PubMed ID: 17545356 [TBL] [Abstract][Full Text] [Related]
5. Effect of growth hormone on exercise tolerance in children with cystic fibrosis. Hütler M; Schnabel D; Staab D; Tacke A; Wahn U; Böning D; Beneke R Med Sci Sports Exerc; 2002 Apr; 34(4):567-72. PubMed ID: 11932561 [TBL] [Abstract][Full Text] [Related]
7. Determinants of aerobic and anaerobic exercise performance in cystic fibrosis. Shah AR; Gozal D; Keens TG Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1145-50. PubMed ID: 9563732 [TBL] [Abstract][Full Text] [Related]
8. A multi-center controlled trial of growth hormone treatment in children with cystic fibrosis. Stalvey MS; Anbar RD; Konstan MW; Jacobs JR; Bakker B; Lippe B; Geller DE Pediatr Pulmonol; 2012 Mar; 47(3):252-63. PubMed ID: 21905270 [TBL] [Abstract][Full Text] [Related]
9. Exercise performance and breathing patterns in cystic fibrosis: male-female differences and influence of resting pulmonary function. Orenstein DM; Nixon PA Pediatr Pulmonol; 1991; 10(2):101-5. PubMed ID: 2030917 [TBL] [Abstract][Full Text] [Related]
10. Cardiopulmonary exercise testing in children with cystic fibrosis: one centre's experience. Weir E; Burns PD; Devenny A; Young D; Paton JY Arch Dis Child; 2017 May; 102(5):440-444. PubMed ID: 27919886 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial. Moss RB; Flume PA; Elborn JS; Cooke J; Rowe SM; McColley SA; Rubenstein RC; Higgins M; Lancet Respir Med; 2015 Jul; 3(7):524-33. PubMed ID: 26070913 [TBL] [Abstract][Full Text] [Related]
12. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections. Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530 [TBL] [Abstract][Full Text] [Related]
13. Effect of supervised training on FEV1 in cystic fibrosis: a randomised controlled trial. Kriemler S; Kieser S; Junge S; Ballmann M; Hebestreit A; Schindler C; Stüssi C; Hebestreit H J Cyst Fibros; 2013 Dec; 12(6):714-20. PubMed ID: 23588193 [TBL] [Abstract][Full Text] [Related]
14. Aerobic exercise and respiratory muscle strength in patients with cystic fibrosis. Dassios T; Katelari A; Doudounakis S; Dimitriou G Respir Med; 2013 May; 107(5):684-90. PubMed ID: 23485096 [TBL] [Abstract][Full Text] [Related]
15. Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial. Davies J; Sheridan H; Bell N; Cunningham S; Davis SD; Elborn JS; Milla CE; Starner TD; Weiner DJ; Lee PS; Ratjen F Lancet Respir Med; 2013 Oct; 1(8):630-638. PubMed ID: 24461666 [TBL] [Abstract][Full Text] [Related]
16. Growth hormone and exercise tolerance in patients with cystic fibrosis. Hütler M; Beneke R Sports Med; 2004; 34(2):81-90. PubMed ID: 14965187 [TBL] [Abstract][Full Text] [Related]
17. Analysis of factors limiting maximal exercise performance in cystic fibrosis. Lands LC; Heigenhauser GJ; Jones NL Clin Sci (Lond); 1992 Oct; 83(4):391-7. PubMed ID: 1330400 [TBL] [Abstract][Full Text] [Related]
19. Usefulness of a program of hospital-supervised physical training in patients with cystic fibrosis. Turchetta A; Salerno T; Lucidi V; Libera F; Cutrera R; Bush A Pediatr Pulmonol; 2004 Aug; 38(2):115-8. PubMed ID: 15211693 [TBL] [Abstract][Full Text] [Related]
20. Assessing the usefulness of outcomes measured in a cystic fibrosis treatment trial. Suri R; Metcalfe C; Wallis C; Bush A Respir Med; 2007 Feb; 101(2):254-60. PubMed ID: 16806875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]